{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:01:53Z","timestamp":1773792113921,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s11307-008-0185-9","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T15:31:15Z","timestamp":1227713475000},"page":"159-166","source":"Crossref","is-referenced-by-count":23,"title":["Biodistributions of 177Lu- and 111In-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of 111In-7E11 as a Pre-therapeutic Agent for 177Lu-7E11 Radioimmunotherapy"],"prefix":"10.1007","volume":"11","author":[{"given":"Mei-Hsiu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Wolodzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin L.","family":"Franc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cncr.22034","volume":"107","author":"GP Swanson","year":"2006","unstructured":"Swanson GP, Thompson IM, Basler J (2006) Current status of lymph node-positive prostate cancer: incidence and predictors of outcome. Cancer 107:439\u2013450","journal-title":"Cancer"},{"key":"185_CR2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.21947","volume":"106","author":"GP Swanson","year":"2006","unstructured":"Swanson GP, Thompson IM, Basler J (2006) Treatment options in lymph node-positive prostate cancer. Cancer 106:2531\u20132539","journal-title":"Cancer"},{"key":"185_CR3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/1097-0142(19930201)71:3+<1098::AID-CNCR2820711432>3.0.CO;2-G","volume":"71","author":"A Yagoda","year":"1993","unstructured":"Yagoda A, Petrylak D (1993) Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 71:1098\u20131109","journal-title":"Cancer"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1200\/JCO.2005.05.160","volume":"23","author":"NH Bander","year":"2005","unstructured":"Bander NH, Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, Goldsmith SJ (2005) Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. J Clin Oncol 23:4591\u20134601","journal-title":"J Clin Oncol"},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00262-003-0457-9","volume":"53","author":"PJ Russell","year":"2004","unstructured":"Russell PJ, Hewish D, Carter T et al (2004) Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunol Immunother 53:411\u2013421","journal-title":"Cancer Immunol Immunother"},{"key":"185_CR6","first-page":"5237","volume":"60","author":"PM Smith-Jones","year":"2000","unstructured":"Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH (2000) In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 60:5237\u20135243","journal-title":"Cancer Res"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0090-4295(96)00184-7","volume":"48","author":"GL Wright Jr","year":"1996","unstructured":"Wright GL Jr, Grob BM, Haley C et al (1996) Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 48:326\u2013334","journal-title":"Urology"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1097-0045(19970701)32:2<140::AID-PROS9>3.0.CO;2-Q","volume":"32","author":"WR Fair","year":"1997","unstructured":"Fair WR, Israeli RS, Heston WD (1997) Prostate-specific membrane antigen. Prostate 32:140\u2013148","journal-title":"Prostate"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1128\/MCB.00084-06","volume":"26","author":"RE Conway","year":"2006","unstructured":"Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH (2006) Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol 26:5310\u20135324","journal-title":"Mol Cell Biol"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ijc.2910620511","volume":"62","author":"JK Troyer","year":"1995","unstructured":"Troyer JK, Beckett ML, Wright GL Jr (1995) Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 62:552\u2013558","journal-title":"Int J Cancer"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N","volume":"30","author":"JK Troyer","year":"1997","unstructured":"Troyer JK, Beckett ML, Wright GL Jr (1997) Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line. Prostate 30:232\u2013242","journal-title":"Prostate"},{"key":"185_CR12","first-page":"927","volume":"7","author":"JS Horoszewicz","year":"1987","unstructured":"Horoszewicz JS, Kawinski E, Murphy GP (1987) Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7:927\u2013935","journal-title":"Anticancer Res"},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0045(19970101)30:1<65::AID-PROS10>3.0.CO;2-N","volume":"30","author":"RJ Barren 3rd","year":"1997","unstructured":"Barren RJ 3rd, Holmes EH, Boynton AL, Misrock SL, Murphy GP (1997) Monoclonal antibody 7E11.C5 staining of viable LNCaP cells. Prostate 30:65\u201368","journal-title":"Prostate"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1097-0045(19981201)37:4<261::AID-PROS8>3.0.CO;2-#","volume":"37","author":"AA Elgamal","year":"1998","unstructured":"Elgamal AA, Troychak MJ, Murphy GP (1998) ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients. Prostate 37:261\u2013269","journal-title":"Prostate"},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.pcan.4500390","volume":"3","author":"MR Feneley","year":"2000","unstructured":"Feneley MR, Jan H, Granowska M et al (2000) Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer. Prostate Cancer Prostatic Dis 3:47\u201352","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"16S","key":"185_CR16","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1200\/jco.2005.23.16_suppl.4765","volume":"23","author":"J Tedesco","year":"2005","unstructured":"Tedesco J, Goeckeler W, Becker M, Frank K, Gulyas G, Young S (2005) Development of optimal Lu-177 labeled monoclonal antibody (7E11) construct (CYT-500) for radioimmunotherapy of hormone refractory prostate cancer. J Clin Oncol 23(16S):4765","journal-title":"J Clin Oncol"},{"key":"185_CR17","unstructured":"Tedesco J, Wolodzco J, Goeckeler W, Becker M, Hasegawa B, Franc B (2006) Development and characterization of a novel 177Lu-MeO-DOTA-7E11 antibody construct (CYT-500) for the treatment and imaging of prostate adenocarcinoma. AACR Annual Meeting"},{"key":"185_CR18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1464-410X.2005.05511.x","volume":"95","author":"V Nargund","year":"2005","unstructured":"Nargund V, Al Hashmi D, Kumar P et al (2005) Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological staging. BJU Int 95:1232\u20131236","journal-title":"BJU Int"},{"key":"185_CR19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/1535-7163.MCT-04-0171","volume":"4","author":"JJ Christiansen","year":"2005","unstructured":"Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, Bander NH, Rajasekaran AK (2005) N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther 4:704\u2013714","journal-title":"Mol Cancer Ther"},{"key":"185_CR20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/01.ju.0000091655.77601.0c","volume":"170","author":"NH Bander","year":"2003","unstructured":"Bander NH, Trabulsi EJ, Kostakoglu L et al (2003) Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol 170:1717\u20131721","journal-title":"J Urol"},{"key":"185_CR21","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2004.09.154","volume":"22","author":"MI Milowsky","year":"2004","unstructured":"Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, Goldsmith SJ, Bander NH (2004) Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. J Clin Oncol 22:2522\u20132531","journal-title":"J Clin Oncol"},{"key":"185_CR22","first-page":"1902","volume":"36","author":"JA O'Donoghue","year":"1995","unstructured":"O'Donoghue JA, Bardies M, Wheldon TE (1995) Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med 36:1902\u20131909","journal-title":"J Nucl Med"},{"key":"185_CR23","first-page":"868","volume":"46","author":"Y Seo","year":"2005","unstructured":"Seo Y, Wong KH, Sun M, Franc BL, Hawkins RA, Hasegawa BH (2005) Correction of photon attenuation and collimator response for a body-contouring SPECT\/CT imaging system. J Nucl Med 46:868\u2013877","journal-title":"J Nucl Med"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-008-0185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-008-0185-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-008-0185-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:36:21Z","timestamp":1559396181000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-008-0185-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s11307-008-0185-9","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}